Are There Clinical Studies Using Cannabis CBD to Treat Panic Attacks in Panic Disorder?

PostedMarch 2, 2026

UpdatedMarch 2, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Researchers are increasingly investigating CBD trials for panic attacks in panic disorder as a potential treatment option. Reviewing cannabidiol clinical trials and other controlled studies, including RCTs, can provide insight into efficacy and safety. Understanding CBD trials for panic attacks helps patients and clinicians assess the potential role of CBD in panic intervention strategies.

Insights from Clinical Studies

Professional evaluation of CBD trials for panic attacks ensures that findings from research are applied safely and effectively in clinical practice.

Cannabidiol Clinical Trials

Cannabidiol clinical trials examine how CBD impacts the frequency and severity of panic attacks, providing controlled data on therapeutic potential.

RCTs

Randomised controlled trials (RCTs) offer rigorous evidence about the effectiveness of CBD in reducing panic symptoms compared with placebo or other interventions.

Panic Intervention Studies

Other panic intervention studies explore dosing strategies, timing, and administration methods to optimise outcomes for patients with panic disorder.

In conclusion, CBD trials for panic attacks provide promising insights, though more research is needed to confirm efficacy. Reviewing cannabidiol clinical trials, RCTs, and other panic intervention studies allows clinicians and patients to make informed decisions regarding CBD use.

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.